The Quinze-Vingts National Ophthalmology Hospital is France's national ophthalmology hospital located in Paris, in the 12th arrondissement. The hospital gave its name to the Quinze-Vingts quarter.

During the past decade, CHNO XV-XX Paris - CIC 1423 conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHNO XV-XX Paris - CIC 1423" #1 collaborator was "Association for Innovation and Biomedical Research on Light and Image" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Carl Zeiss Meditec AG" with 1 trials as a collaborator, "City, University of London" with 1 trials as a collaborator and "European Clinical Research Infrastructure Network" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "CHNO XV-XX Paris - CIC 1423" are "Age Related Macular Degeneration (AMD)" (1 trials), "High Risk Proliferative Diabetic Retinopathy" (1 trials), "Retinitis Pigmentosa" (1 trials) and "Retinitis Pigmentosa (RP)" (1 trials). Many other conditions were trialed in "CHNO XV-XX Paris - CIC 1423" in a lesser frequency.

Most popular intervention types in "CHNO XV-XX Paris - CIC 1423" are "Other" (2 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Intravitreous injection of ranibizumab" (1 trials), "Mobility Test" (1 trials), "No intervention" (1 trials), "Ophthalmic examinations" (1 trials) and "Panretinal Photocoagulation (PRP)" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHNO XV-XX Paris - CIC 1423" are 4 trials for "All" genders.

Currently, there are NaN active trials in "CHNO XV-XX Paris - CIC 1423". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in CHNO XV-XX Paris - CIC 1423, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHNO XV-XX Paris - CIC 1423, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".